Regenerative Medicine

Yun Xia presents macrophage–kidney assembloids that address missing immune and vascular components in stem-cell organoids. Directed differentiation, self-organization, genetic perturbation, xenotransplantation and single-cell analysis reveal immune–epithelial interactions. Macrophages from the same parental cells acquire resident phenotypes; diabetic and polycystic kidney models show context-dependent effects on inflammation, epithelial injury and disease progression. Minoru Takasato addresses kidney organoids’ missing urinary outflow by generating bladder tissue from human pluripotent cells. Stepwise differentiation passes through endoderm, hindgut and cloaca; FGF4 posteriorization and growth-factor screening promote urothelial identity. The resulting sacs contain stratified urothelial cell types, stretch and form a barrier, supporting developmental, disease and future therapeutic studies. Online via Zoom. Tuesday 13 October, 11:00–12:30 SGT (Asia/Singapore). Both talks share this session; individual start times are unspecified. Register through the organizer page. Professional, trainee or student status in stem cells, regenerative medicine or an adjacent field is required; organizer approval and recording restrictions apply.

Annual meeting of the International Society for Stem Cell Research at the Moscone West Convention Center, San Francisco, recognizing 25 years of discovery, collaboration, and progress in stem cell science.

Lead an independent research group at the Australian Regenerative Medicine Institute, aligned with heart and muscle regeneration, immunity, neural regeneration, organ engineering, synthetic biology, or stem cells. The full-time appointment offers an initial term of up to five years within the EMBL Australia Partner Laboratory Network. Responsibilities include original research, mentoring, external funding and collaborations. Applications close on 2 October 2026 at 11:55 pm AEST.

Yun Xia presents macrophage–kidney assembloids that address missing immune and vascular components in stem-cell organoids. Directed differentiation, self-organization, genetic perturbation, xenotransplantation and single-cell analysis reveal immune–epithelial interactions. Macrophages from the same parental cells acquire resident phenotypes; diabetic and polycystic kidney models show context-dependent effects on inflammation, epithelial injury and disease progression. Minoru Takasato addresses kidney organoids’ missing urinary outflow by generating bladder tissue from human pluripotent cells. Stepwise differentiation passes through endoderm, hindgut and cloaca; FGF4 posteriorization and growth-factor screening promote urothelial identity. The resulting sacs contain stratified urothelial cell types, stretch and form a barrier, supporting developmental, disease and future therapeutic studies. Online via Zoom. Tuesday 13 October, 11:00–12:30 SGT (Asia/Singapore). Both talks share this session; individual start times are unspecified. Register through the organizer page. Professional, trainee or student status in stem cells, regenerative medicine or an adjacent field is required; organizer approval and recording restrictions apply.

Develop optical systems for biofabrication at ETH Zurich’s Institute for Biomechanics. The researcher will design and build optical and beam-shaping systems, study the interaction of structured light with photosensitive polymers, and collaborate with bioengineers, chemists and biologists on scaffolds for regenerative medicine. This full-time postdoctoral position is funded for 1.5 years. The current vacancy accepts online applications without a stated closing date; provide a CV, publication list and references.

Develop medical materials that control biological responses, including healing, immune regulation, stem-cell differentiation or timed drug delivery. Several permanent research positions are available in the Research Center for Macromolecules and Biomaterials. The expected start is 1 April 2027, negotiable. Applications are reviewed as received and accepted while this vacancy remains on the official NIMS website.

Lead an independent research group at the Australian Regenerative Medicine Institute, aligned with heart and muscle regeneration, immunity, neural regeneration, organ engineering, synthetic biology, or stem cells. The full-time appointment offers an initial term of up to five years within the EMBL Australia Partner Laboratory Network. Responsibilities include original research, mentoring, external funding and collaborations. Applications close on 2 October 2026 at 11:55 pm AEST.